Mature T lymphocyte (T cell)

Mature T cells are a specialized population of lymphocytes that play a pivotal role in the adaptive immune system. Originating from hematopoietic stem cells in the bone marrow and maturing in the thymus, these cells are defined by the expression of the T-cell receptor (TCR) complex, which allows them to recognize specific antigens presented by major histocompatibility complex (MHC) molecules (StatPearls, 2023). They are broadly categorized into helper T cells (CD4+), which coordinate immune responses through cytokine secretion, and cytotoxic T cells (CD8+), which directly eliminate infected or malignant cells (NIH, 2022). In therapeutic contexts, mature T cells are targeted to manage conditions such as autoimmune diseases, organ transplant rejection, and T-cell leukemias or lymphomas. Pharmacological intervention typically involves depleting the T-cell population using monoclonal antibodies or inhibiting their activation and proliferation through immunosuppressive agents that target signaling molecules like calcineurin or mTOR (DrugBank, 2024).

Other names

T lymphocyteCD3+ cellThymus-derived lymphocyteT-cell

Drugs targeting mature T cells act through various mechanisms including direct cell depletion via antibody-dependent cellular cytotoxicity (ADCC), blockade of the T-cell receptor (TCR) complex, inhibition of intracellular signaling pathways like calcineurin or mTOR, and interference with co-stimulatory signals required for activation.